findmyKOL
Clinical trialNCT06820957Active, not recruitingPhase 2/PHASE3Interventional

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

SponsorChildren's Oncology GroupEnrollment437CIC-Rearranged SarcomaMetastatic Ewing SarcomaMetastatic High Grade SarcomaMetastatic Undifferentiated Round Cell SarcomaMetastatic Undifferentiated Sarcoma, Not Otherwise SpecifiedRound Cell Sarcoma With EWSR1-non-ETS Fusion+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S Hospital of Alabama

    Birmingham, Alabama, United States

  • Kapiolani Medical Center for Women and Children

    Honolulu, Hawaii, United States

  • Lurie Children'S Hospital-Chicago

    Chicago, Illinois, United States

  • Osf Children'S Hospital of Illinois

    Peoria, Illinois, United States

  • Nyu Langone Hospital - Long Island

    Mineola, New York, United States

  • Saint Christopher'S Hospital for Children

    Philadelphia, Pennsylvania, United States

  • Prisma Health Richland Hospital

    Columbia, South Carolina, United States

  • Bi-Lo Charities Children'S Cancer Center

    Greenville, South Carolina, United States

  • East Tennessee Childrens Hospital

    Knoxville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Nov 2025
Primary completion
31 Dec 2027
Completion
31 Dec 2027
Last update posted
23 Jun 2026
Registered enrollment
437
Registry id
NCT06820957

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.